ESR1 and osteoporosis: Among the 276 patients, 259 (93.8%) patients had received treatment for osteoporosis, which included bisphosphonate, selective estrogen receptor modulators, denosumab, teriparatide, and activated vitamin D. Seventeen patients were not under any medical osteoporosis treatment.